Sandra Belij-Rammerstorfer
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Immunization, Secondary | 4 | 2021 | 1649 | 0.21 | Why? |
| Chlamydophila | 1 | 2017 | 4 | 0.18 | Why? |
| Dinitrochlorobenzene | 1 | 2017 | 2 | 0.18 | Why? |
| Haptens | 1 | 2017 | 7 | 0.18 | Why? |
| Chlamydophila Infections | 1 | 2017 | 21 | 0.18 | Why? |
| Antibody Formation | 2 | 2020 | 4038 | 0.16 | Why? |
| Immunogenicity, Vaccine | 3 | 2021 | 4624 | 0.16 | Why? |
| Viral Vaccines | 3 | 2020 | 7560 | 0.14 | Why? |
| Macaca mulatta | 2 | 2021 | 3716 | 0.13 | Why? |
| Warfarin | 1 | 2017 | 402 | 0.12 | Why? |
| Immunity, Cellular | 3 | 2020 | 3614 | 0.11 | Why? |
| Immunity, Humoral | 3 | 2020 | 4849 | 0.10 | Why? |
| Dose-Response Relationship, Immunologic | 2 | 2020 | 593 | 0.09 | Why? |
| Protein Subunits | 2 | 2020 | 755 | 0.09 | Why? |
| Antibodies, Monoclonal | 3 | 2021 | 8041 | 0.08 | Why? |
| Single-Blind Method | 2 | 2020 | 1283 | 0.08 | Why? |
| T-Lymphocytes | 2 | 2020 | 6670 | 0.08 | Why? |
| Antibodies, Neutralizing | 6 | 2021 | 25288 | 0.07 | Why? |
| Th1 Cells | 2 | 2021 | 1228 | 0.07 | Why? |
| Spike Glycoprotein, Coronavirus | 7 | 2021 | 37182 | 0.06 | Why? |
| Genetic Vectors | 2 | 2020 | 1600 | 0.06 | Why? |
| Disease Models, Animal | 1 | 2020 | 10998 | 0.06 | Why? |
| Animals | 9 | 2021 | 78931 | 0.06 | Why? |
| Antibodies, Viral | 4 | 2021 | 51949 | 0.06 | Why? |
| Vaccination | 3 | 2021 | 19050 | 0.05 | Why? |
| Adenoviruses, Simian | 1 | 2020 | 52 | 0.05 | Why? |
| Neutrophils | 1 | 2017 | 5476 | 0.05 | Why? |
| Vero Cells | 3 | 2021 | 14117 | 0.05 | Why? |
| Antigen-Antibody Complex | 1 | 2021 | 408 | 0.05 | Why? |
| Analgesics, Non-Narcotic | 1 | 2020 | 164 | 0.05 | Why? |
| CHO Cells | 1 | 2021 | 831 | 0.05 | Why? |
| Respiratory Burst | 1 | 2017 | 16 | 0.04 | Why? |
| Cricetulus | 1 | 2021 | 936 | 0.04 | Why? |
| Eye Infections | 1 | 2017 | 20 | 0.04 | Why? |
| Vaccines, Synthetic | 2 | 2021 | 3231 | 0.04 | Why? |
| Acetaminophen | 1 | 2020 | 326 | 0.04 | Why? |
| Neutralization Tests | 2 | 2021 | 6698 | 0.04 | Why? |
| HEK293 Cells | 2 | 2021 | 8394 | 0.04 | Why? |
| T-Lymphocytes, Cytotoxic | 1 | 2021 | 552 | 0.04 | Why? |
| Guinea Pigs | 1 | 2017 | 420 | 0.04 | Why? |
| Peroxidase | 1 | 2017 | 207 | 0.04 | Why? |
| Administration, Topical | 1 | 2017 | 272 | 0.04 | Why? |
| Anticoagulants | 1 | 2017 | 9563 | 0.04 | Why? |
| Partial Thromboplastin Time | 1 | 2017 | 436 | 0.04 | Why? |
| Ferrets | 1 | 2021 | 1201 | 0.04 | Why? |
| Prothrombin Time | 1 | 2017 | 434 | 0.04 | Why? |
| Immunization, Passive | 2 | 2021 | 10067 | 0.03 | Why? |
| Vaccines, Attenuated | 1 | 2020 | 952 | 0.03 | Why? |
| Structure-Activity Relationship | 1 | 2021 | 2219 | 0.03 | Why? |
| Protein Binding | 2 | 2021 | 11430 | 0.03 | Why? |
| Adenoviridae | 1 | 2020 | 1151 | 0.03 | Why? |
| Crystallography, X-Ray | 1 | 2021 | 2689 | 0.03 | Why? |
| Vaccines, DNA | 1 | 2020 | 871 | 0.03 | Why? |
| RNA, Viral | 1 | 2021 | 32276 | 0.03 | Why? |
| Immunoglobulin G | 3 | 2020 | 21571 | 0.03 | Why? |
| Dose-Response Relationship, Drug | 1 | 2020 | 3776 | 0.03 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2020 | 2309 | 0.03 | Why? |
| Clinical Trials as Topic | 2 | 2021 | 7330 | 0.03 | Why? |
| Mice | 2 | 2021 | 21357 | 0.03 | Why? |
| Lymphocyte Activation | 1 | 2020 | 2742 | 0.03 | Why? |
| Interferon-gamma | 1 | 2020 | 2711 | 0.03 | Why? |
| Nitric Oxide | 1 | 2017 | 769 | 0.03 | Why? |
| Virulence | 1 | 2017 | 2172 | 0.03 | Why? |
| United Kingdom | 2 | 2020 | 18046 | 0.02 | Why? |
| Administration, Oral | 1 | 2017 | 2340 | 0.02 | Why? |
| Rats | 1 | 2017 | 2764 | 0.02 | Why? |
| Immunoglobulin A | 1 | 2020 | 3567 | 0.02 | Why? |
| Immunomodulation | 1 | 2017 | 1472 | 0.02 | Why? |
| Protein Domains | 1 | 2021 | 6563 | 0.02 | Why? |
| Leukocyte Count | 1 | 2017 | 3178 | 0.02 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2017 | 2483 | 0.02 | Why? |
| Models, Molecular | 1 | 2021 | 7616 | 0.02 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.02 | Why? |
| Adolescent | 3 | 2020 | 86841 | 0.02 | Why? |
| Pandemics | 4 | 2021 | 389249 | 0.02 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2020 | 4545 | 0.02 | Why? |
| Young Adult | 3 | 2020 | 93724 | 0.02 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2020 | 5837 | 0.02 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.02 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.02 | Why? |
| Immunoglobulin M | 1 | 2020 | 9091 | 0.02 | Why? |
| Humans | 8 | 2021 | 930598 | 0.01 | Why? |
| Male | 5 | 2020 | 367725 | 0.01 | Why? |
| Mutation | 1 | 2021 | 12376 | 0.01 | Why? |
| Viral Load | 1 | 2020 | 15850 | 0.01 | Why? |
| Female | 4 | 2020 | 380317 | 0.01 | Why? |
| Age Factors | 1 | 2020 | 21039 | 0.01 | Why? |
| Interleukin-6 | 1 | 2017 | 7522 | 0.01 | Why? |
| Adult | 3 | 2020 | 244371 | 0.01 | Why? |
| Cytokines | 1 | 2020 | 15010 | 0.01 | Why? |
| Middle Aged | 3 | 2020 | 270681 | 0.01 | Why? |
| Time Factors | 1 | 2020 | 31397 | 0.01 | Why? |
| Lung | 1 | 2020 | 31049 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2020 | 88759 | 0.01 | Why? |
| Aged | 1 | 2020 | 215776 | 0.00 | Why? |